Related Experiment Videos

Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance

V Schirrmacher1, U Beutner, M Bucur

  • 1Division of Cellular Immunology, German Cancer Research Center, Heidelberg. v.schirrmacher@dkfz-heidelberg.de

Insights

Tumor resistance in mice is linked to the absence of Mtv-7, a specific viral superantigen. Removing Mtv-7 enhances resistance, while its presence increases tumor susceptibility.

Area of Science:

  • Immunogenetics
  • Virology
  • Oncology

Background:

  • Recombinant inbred mouse strains were developed from tumor-susceptible (DBA/2) and tumor-resistant (B10.D2) parents.
  • Tumor resistance has an immunologic basis and is influenced by endogenous viral superantigens (vSAGs).

Purpose of the Study:

  • To investigate the genetic basis of tumor resistance in new recombinant inbred mouse strains.
  • To identify specific endogenous mouse mammary tumor viruses (Mtvs) associated with tumor resistance.

Main Methods:

  • DNA typing of recombinant inbred mouse lines for endogenous mouse mammary tumor viruses using Mtv long terminal repeat and env gene probes.
  • Southern blot analysis to detect Mtv proviruses.
  • Backcross analysis to assess the association between Mtv-7 and tumor resistance.

Main Results:

  • Resistant D2 x D mice lacked Mtv-7, a provirus encoding the Mls-1a superantigen.
  • Mtv-7-negative F2 mice showed significantly higher resistance to tumors compared to Mtv-7-positive F2 mice.
  • Reintroduction of Mtv-7 into resistant lines increased tumor susceptibility.

Conclusions:

  • The absence of Mtv-7 is strongly correlated with tumor resistance.
  • Mtv-7 plays a crucial role in modulating tumor susceptibility.
  • Immunoresistance and graft-vs-leukemia reactivity can be transferred between mice.

Related Concept Videos